The ROLE OF INFLAMMATORY MARKERS IN AUTOIMMUNE RHEUMATIC DISEASES
Keywords:
autoimmune diseases, rheumatic diseases, inflammatory markers, cytokines, C-reactive protein, erythrocyte sedimentation rate, diagnosis, disease activity, biomarkers, immunopathogenesis.Abstract
Autoimmune rheumatic diseases represent a diverse and complex
group of disorders in which the immune system mistakenly targets the body's own
tissues, resulting in chronic inflammation and tissue damage across multiple organ
systems. These diseases, such as rheumatoid arthritis, systemic lupus erythematosus,
and Sjögren's syndrome, are characterized by their heterogeneous clinical
manifestations, unpredictable course, and potential for significant morbidity. In the
management of these disorders, early and accurate assessment of disease activity as
well as timely monitoring of treatment response are critical. Among various tools used
in clinical practice, inflammatory markers play a central role in both the diagnosis and
ongoing evaluation of autoimmune rheumatic diseases.
References
1. Aletaha, D., & Smolen, J. S. (2018). Diagnosis and management of rheumatoid
arthritis: A review. JAMA, 320(13), 1360-1372.
2. Boulos, P. T., Davis, S. A., & Feldman, S. R. (2020). Biomarkers in
autoimmune diseases: Current and future directions. Current Allergy and Asthma
Reports, 20(10), 52.
3. Deane, K. D., & Holers, V. M. (2019). The natural history of rheumatoid
arthritis. Clinics in Geriatric Medicine, 35(3), 407-418.
4. Firestein, G. S., & McInnes, I. B. (2017). Immunopathogenesis of rheumatoid
arthritis. Immunity, 46(2), 183-196.
5. Li, J., & Chen, Y. (2022). Inflammatory biomarkers in autoimmune diseases:
Pathogenesis and clinical application. Frontiers in Immunology, 13, 840885.
6. Marzaioli, V., Piccio, L., & Deana, C. (2019). Inflammation and biomarkers in
systemic lupus erythematosus. Journal of Clinical Medicine, 8(8), 1201.
7. Pepys, M. B., & Hirschfield, G. M. (2019). C-reactive protein: A critical update.
Journal of Clinical Investigation, 129(12), 5351-5357.
